FDA Import Refusal AEK-4736212-2/11/1 — Novartis Pharma AG
The FDA refused shipment AEK-4736212-2/11/1 from Novartis Pharma AG (Switzerland) on Mar 18, 2024. The refused product falls under Drugs and Biologics — METFORMIN (ANTI-DIABETIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Mar 18, 2024
- Country
- Switzerland
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY26 METFORMIN (ANTI-DIABETIC)
- Charges
- 118,75